TIS are looking good at the moment, as they are entering a pretty risk free period, now they are cashed up.
During this time we will see further progress towards the trial, which should go well as the others have.
Negotiations with partners are happening soon (according to tis).
As they have the best cheap product for a >$4b market, the future looks good.
buy and hold for at least two years imho